Literature DB >> 457862

Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70.

J S Goodwin, R P Messner.   

Abstract

We examined the sensitivity of lymphocytes from different age groups to inhibition by prostaglandin E2. Phytohemagglutinin-stimulated cultures of peripheral blood mononuclear cells from 12 healthy subjects over the age of 70 were much more sensitive to inhibition by exogenously added prostaglandin E2 than were cells from 17 young controls (ID50 congruent to 10 nM for the subjects over 70 vs. greater than 3 micronM for the young controls). The more senstivie lymphocytes from a subject over 70 were to prostaglandin E2, the lower was his or her response to phytohemagglutinin (r = 0.75, P less than 0.01). The mean responses to phytohemagglutinin of the peripheral blood mononuclear cells from the subjects over 70 were significantly depressed compared to the young controls. Addition of indomethacin, a prostaglandin synthetase inhibitor, to the cultures resulted in an increase in [3H]thymidine incorporation of 140 +/- 16% in the cells of the subjects over 70 vs. a 36 +/- 3% increase in the young controls (mean +/- SEM, P less than 0.001). The mean phytohemagglutinin response of the subjects over 70 was 40% of the control response without indomethacin. With addition of indomethacin the response of subjects over 70 rose to 72% of control. Thus, increased sinsitivity to prostaglandin E2 appears to be responsible in part for the depressed mitogen response of peripheral blood mononuclear cells from healthy subjects over 70.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457862      PMCID: PMC372137          DOI: 10.1172/JCI109480

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis.

Authors:  M W Chase
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

2.  Selective service and military medical manpower.

Authors:  J C Cain
Journal:  JAMA       Date:  1968-01-08       Impact factor: 56.272

3.  Decreased lymphocyte reactivity to a suboptimal concentration of phytohemagglutinin in Sjögren's syndrome.

Authors:  J P Michalski; C McCombs
Journal:  Arthritis Rheum       Date:  1977-04

4.  Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin.

Authors:  J S Goodwin; A D Bankhurst; S A Murphy; D S Selinger; R P Messner; R C Williams
Journal:  J Clin Lab Immunol       Date:  1978-11

5.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

6.  DNA synthesis and proliferation of human lymphocytes in vitro. I. Cell kinetics of response to phytohemagglutinin.

Authors:  J L Bernheim; R E Dorian; J Mendelsohn
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

7.  Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.

Authors:  J S Goodwin; R P Messner; G T Peake
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

8.  Effect of indomethacin in vivo on humoral and cellular immunity in humans.

Authors:  J S Goodwin; D S Selinger; R P Messner; W P Reed
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Immunological studies of Aging. III. Cytokinetic basis for the impaired response of lymphocytes from aged humans to plant lectins.

Authors:  B Inkeles; J B Innes; M M Kuntz; A S Kadish; M E Weksler
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

10.  Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice.

Authors:  E A Goidl; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  21 in total

Review 1.  Vascular aging: chronic oxidative stress and impairment of redox signaling-consequences for vascular homeostasis and disease.

Authors:  Markus M Bachschmid; Stefan Schildknecht; Reiko Matsui; Rebecca Zee; Dagmar Haeussler; Richard A Cohen; David Pimental; Bernd van der Loo
Journal:  Ann Med       Date:  2012-03-01       Impact factor: 4.709

2.  Null cell senescence and its potential significance to the immunobiology of aging.

Authors:  J J Twomey; R J Luchi; N M Kouttab
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

3.  Immunological responses of healthy elderly population.

Authors:  J S Goodwin; R P Searles; K S Tung
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

4.  Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.

Authors:  J Passwell; M Levanon; J Davidsohn; B Ramot
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

5.  Age-related differences in the effect of in vivo administration of indomethacin on hemopoietic cell lineages of the spleen and bone marrow of mice.

Authors:  S C Miller
Journal:  Experientia       Date:  1992-07-15

6.  Monocyte-mediated regulation of cellular immunity in humans: loss of suppressor activity with ageing.

Authors:  M J Becker; I Drucker; R Farkas; Z Steiner; A Klajman
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

Review 7.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

8.  Age-related effects on the number of human lymphocytes in culture initially responding to an antigenic stimulus.

Authors:  P G Sohnle; C Collins-Lech; K E Huhta
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

Review 9.  Special considerations required for the formulation and administration of total parenteral nutrition therapy in the elderly patient.

Authors:  D F Driscoll; B R Bistrian
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

10.  Spectrum of immunodeficiencies with Hodgkin's disease.

Authors:  J J Twomey; A H Laughter; L Rice; R Ford
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.